Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database

Breakpoint cluster region‐Abelson murine leukemia (BCR‐ABL) inhibitors markedly improve the prognosis of chronic myeloid leukemia. However, high treatment adherence is necessary for successful treatment with BCR‐ABL inhibitors. Therefore, an adequate understanding of the adverse event profiles of BC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Okada, Naoto, Niimura, Takahiro, Zamami, Yoshito, Hamano, Hirofumi, Ishida, Shunsuke, Goda, Mitsuhiro, Takechi, Kenshi, Chuma, Masayuki, Imanishi, Masaki, Ishizawa, Keisuke
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346261/
https://ncbi.nlm.nih.gov/pubmed/30561126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1920
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados